MeiraGTx Holdings (MGTX) Preferred Dividend Payments (2017 - 2018)
MeiraGTx Holdings (MGTX) reported Preferred Dividend Payments of $1.1 million for Q2 2018, up 3655.78% on a YoY basis from $30401.0 in Q2 2017, and up 71.77% quarter-over-quarter from $664718.0 in Q1 2018.
MeiraGTx Holdings (MGTX) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
MeiraGTx Holdings has reported Preferred Dividend Payments for 2 years, with the latest figure at $1.1 million in Q2 2018.
- For the quarter ending Q2 2018, Preferred Dividend Payments rose 3655.78% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2018 stood at $1.8 million (changed N/A YoY), and the FY2018 full-year result was $1.8 million, up 123.87% from the prior year.
- Preferred Dividend Payments for Q2 2018 stood at $1.1 million, up from $664718.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $1.1 million in Q2 2018, with the low at $30401.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 1.14 Mn |
| Mar 31, 2018 | 664,718.00 |
| Dec 31, 2017 | 562,043.00 |
| Sep 30, 2017 | 191,758.00 |
| Jun 30, 2017 | 30,401.00 |